Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study

Introduction: Carcinoma of gallbladder is an aggressive disease with poor outcome. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane receptor that regulate growth, proliferation and differentiation in cells. Increased EGFR receptor expression has been studied in various cancers like lun...

Full description

Bibliographic Details
Main Authors: Tatton Perme, Malti Kumari Maurya, Preeti Agarwal, Madhu Kumar, Mala Sagar, Madhu Mati Goel, Abhijit Chandra
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/16900/55396_CE(AD)_F[SH]_PF1_(AG_OM)_PFA(KM_AG)_PN(KM).pdf
_version_ 1797901453534167040
author Tatton Perme
Malti Kumari Maurya
Preeti Agarwal
Madhu Kumar
Mala Sagar
Madhu Mati Goel
Abhijit Chandra
author_facet Tatton Perme
Malti Kumari Maurya
Preeti Agarwal
Madhu Kumar
Mala Sagar
Madhu Mati Goel
Abhijit Chandra
author_sort Tatton Perme
collection DOAJ
description Introduction: Carcinoma of gallbladder is an aggressive disease with poor outcome. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane receptor that regulate growth, proliferation and differentiation in cells. Increased EGFR receptor expression has been studied in various cancers like lung, colorectal, breast and pancreatic tumours and anti-EGFR antibody has been used successfully for therapeutic and diagnostic purposes. Aim: To evaluate EGFR expression in gallbladder carcinoma and its association with clinicopathological factors to reveal its relation to prognosis. Materials and Methods: This cross-sectional retrospective observational study in which 64 samples were collected of resected specimen of Gallbladder Carcinoma (GBC), from the Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India, between March 2017 to September 2018. Haematoxylin and Eosin (H&E) stained sections were evaluated for tumour type and histopathological grading and TNM staging was done. Immunohistochemistry (IHC) was performed and analysed prospectively using ready to use anti-EGFR as per manufacturer’s protocols. Association between EGFR expression and clinicopathological factors were statistically analysed using Statistical Package for the Social Sciences (SPSS) software version 21.0. Results: The EGFR expression was positive in 52 (81.25%) cases of GBC which showed a highly significant association between tumour grade and stage. About 60% of poorly differentiated GBC displayed strong (3+) staining intensity as compared to 30% of moderately differentiated (3+) and 10% of well differentiated tumours (3+). It suggests that with decreasing differentiation of tumour EGFR staining intensity increases (p<0.001). Positivity rate of EGFR expression were also increased with increase of tumour TNM stage (stage I to stage IV). Strong EGFR expression was associated with decreased overall survival with significant p value (p=0.031, log rank test). Conclusion: The EGFR expression is inversely related with tumour differentiation, and overall survival. EGFR expression increases with high TNM staging. So, it can be used as prognostic marker for gallbladder carcinoma and opening a hope towards the new therapeutic options.
first_indexed 2024-04-10T09:02:17Z
format Article
id doaj.art-88c0868f0a55444ab7b908d9a84fd1e2
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T09:02:17Z
publishDate 2022-09-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-88c0868f0a55444ab7b908d9a84fd1e22023-02-21T11:50:42ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-09-01169EC41EC4510.7860/JCDR/2022/55396.16900Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional StudyTatton Perme0Malti Kumari Maurya1Preeti Agarwal2Madhu Kumar3Mala Sagar4Madhu Mati Goel5Abhijit Chandra6Ex-Postgraduate Student, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Additional Professor, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Additional Professor, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Additional Professor, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Additional Professor, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Professor, Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Professor, Department of Surgical Gastroenterology, King George’s Medical University, Lucknow, Uttar Pradesh, India.Introduction: Carcinoma of gallbladder is an aggressive disease with poor outcome. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane receptor that regulate growth, proliferation and differentiation in cells. Increased EGFR receptor expression has been studied in various cancers like lung, colorectal, breast and pancreatic tumours and anti-EGFR antibody has been used successfully for therapeutic and diagnostic purposes. Aim: To evaluate EGFR expression in gallbladder carcinoma and its association with clinicopathological factors to reveal its relation to prognosis. Materials and Methods: This cross-sectional retrospective observational study in which 64 samples were collected of resected specimen of Gallbladder Carcinoma (GBC), from the Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India, between March 2017 to September 2018. Haematoxylin and Eosin (H&E) stained sections were evaluated for tumour type and histopathological grading and TNM staging was done. Immunohistochemistry (IHC) was performed and analysed prospectively using ready to use anti-EGFR as per manufacturer’s protocols. Association between EGFR expression and clinicopathological factors were statistically analysed using Statistical Package for the Social Sciences (SPSS) software version 21.0. Results: The EGFR expression was positive in 52 (81.25%) cases of GBC which showed a highly significant association between tumour grade and stage. About 60% of poorly differentiated GBC displayed strong (3+) staining intensity as compared to 30% of moderately differentiated (3+) and 10% of well differentiated tumours (3+). It suggests that with decreasing differentiation of tumour EGFR staining intensity increases (p<0.001). Positivity rate of EGFR expression were also increased with increase of tumour TNM stage (stage I to stage IV). Strong EGFR expression was associated with decreased overall survival with significant p value (p=0.031, log rank test). Conclusion: The EGFR expression is inversely related with tumour differentiation, and overall survival. EGFR expression increases with high TNM staging. So, it can be used as prognostic marker for gallbladder carcinoma and opening a hope towards the new therapeutic options.https://jcdr.net/articles/PDF/16900/55396_CE(AD)_F[SH]_PF1_(AG_OM)_PFA(KM_AG)_PN(KM).pdfadenocarcinomagallbladder cancerimmunohistochemistryprognostic marker
spellingShingle Tatton Perme
Malti Kumari Maurya
Preeti Agarwal
Madhu Kumar
Mala Sagar
Madhu Mati Goel
Abhijit Chandra
Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
Journal of Clinical and Diagnostic Research
adenocarcinoma
gallbladder cancer
immunohistochemistry
prognostic marker
title Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
title_full Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
title_fullStr Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
title_full_unstemmed Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
title_short Role of Epidermal Growth Factor Receptor in Gallbladder Carcinoma and its Association with Various Clinicopathological Parameters: A Cross-sectional Study
title_sort role of epidermal growth factor receptor in gallbladder carcinoma and its association with various clinicopathological parameters a cross sectional study
topic adenocarcinoma
gallbladder cancer
immunohistochemistry
prognostic marker
url https://jcdr.net/articles/PDF/16900/55396_CE(AD)_F[SH]_PF1_(AG_OM)_PFA(KM_AG)_PN(KM).pdf
work_keys_str_mv AT tattonperme roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT maltikumarimaurya roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT preetiagarwal roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT madhukumar roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT malasagar roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT madhumatigoel roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy
AT abhijitchandra roleofepidermalgrowthfactorreceptoringallbladdercarcinomaanditsassociationwithvariousclinicopathologicalparametersacrosssectionalstudy